BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21401612)

  • 1. Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis.
    Ma T; Huang C; Zong G; Zha D; Meng X; Li J; Tang W
    J Pharm Pharmacol; 2011 Apr; 63(4):587-93. PubMed ID: 21401612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
    Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effects of compound glycyrrhizin liposome on fibrosis of the rats with nonalcoholic steatohepatitis].
    Ye HJ; Wei SL; Wang HC; Liu XY; Wan HJ; Yi XR; Yuan YC; Kong XP
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):877-8. PubMed ID: 19958654
    [No Abstract]   [Full Text] [Related]  

  • 4. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
    Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis.
    Yang HY; Tzeng YH; Chai CY; Hsieh AT; Chen JR; Chang LS; Yang SS
    Nutrition; 2011 Sep; 27(9):943-8. PubMed ID: 21333494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effects of total flavonoids of Litsea coreana leve on hepatic steatosis in rats fed with high fat diet.
    Wang JQ; Li J; Zou YH; Cheng WM; Lu C; Zhang L; Ge JF; Huang C; Jin Y; Lv XW; Hu CM; Liu LP
    J Ethnopharmacol; 2009 Jan; 121(1):54-60. PubMed ID: 18977425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease.
    Duan XY; Zhao HP; Fan JG
    J Dig Dis; 2010 Apr; 11(2):94-100. PubMed ID: 20402835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ; Li LD; Wu LM
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Staels B; Rubenstrunk A; Noel B; Rigou G; Delataille P; Millatt LJ; Baron M; Lucas A; Tailleux A; Hum DW; Ratziu V; Cariou B; Hanf R
    Hepatology; 2013 Dec; 58(6):1941-52. PubMed ID: 23703580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis.
    Zou Y; Li J; Lu C; Wang J; Ge J; Huang Y; Zhang L; Wang Y
    Life Sci; 2006 Aug; 79(11):1100-7. PubMed ID: 16624332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis.
    IbaƱez P; Solis N; Pizarro M; Aguayo G; Duarte I; Miquel JF; Accatino L; Arrese M
    J Gastroenterol Hepatol; 2007 Jun; 22(6):846-51. PubMed ID: 17565640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease.
    Hong X; Tang H; Wu L; Li L
    J Pharm Pharmacol; 2006 Oct; 58(10):1391-8. PubMed ID: 17034663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen-rich saline protects against liver injury in rats with obstructive jaundice.
    Liu Q; Shen WF; Sun HY; Fan DF; Nakao A; Cai JM; Yan G; Zhou WP; Shen RX; Yang JM; Sun XJ
    Liver Int; 2010 Aug; 30(7):958-68. PubMed ID: 20492513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats.
    Murayama H; Ikemoto M; Nagata A
    J Gastroenterol Hepatol; 2009 Feb; 24(2):270-7. PubMed ID: 18823438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats.
    Pan M; Song YL; Xu JM; Gan HZ
    J Pineal Res; 2006 Aug; 41(1):79-84. PubMed ID: 16842545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis.
    Takayama F; Nakamoto K; Totani N; Yamanushi T; Kabuto H; Kaneyuki T; Mankura M
    J Oleo Sci; 2010; 59(8):407-14. PubMed ID: 20625232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
    Tan Y; Zhang JN; Chen JH; Wang LJ; Liu HX
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):821-5. PubMed ID: 19958640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.